Shuji Arita

Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumours

Takashi Seto, Taito Esaki, Fumihiko Hirai et al. · Cancer Chemotherapy and Pharmacology · 2013 · 101 citations

Dose-escalation Study, Radiation Medicine, Medicine +10

Safety and tolerability of AZD5363 in Japanese patients with advanced solid tumors

Kenji Tamura, Jun Hashimoto, Yuko Tanabe et al. · Cancer Chemotherapy and Pharmacology · 2016 · 58 citations · Full text

Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer

Akitaka Makiyama, Kohei Arimizu, Gen Hirano et al. · Gastric Cancer · 2017 · 56 citations · Full text

Irinotecan Monotherapy, Surgical Oncology, Gastrointestinal Oncology +9

B cell activation regulates exosomal HLA production

Shuji Arita, Eishi Baba, Yoshihiro Shibata et al. · European Journal of Immunology · 2008 · 50 citations

Human STEAP3 maintains tumor growth under hypoferric condition

Taichi Isobe, Eishi Baba, Shuji Arita et al. · Experimental Cell Research · 2011 · 45 citations

Tumor Biology, Human Steap3, Pathology +4